FJACX
Price
$12.70
Change
+$0.09 (+0.71%)
Updated
Jul 31 closing price
Net Assets
1.96B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FJACX vs VSCIX

FJACX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
FJACX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FJACX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. FJACX (1.96B). VSCIX pays higher dividends than FJACX: VSCIX (1.23) vs FJACX (0.93). FJACX was incepted earlier than VSCIX: FJACX (13 years) vs VSCIX (29 years). VSCIX (0.03) is less costly to investors than FJACX (0.00). FJACX is a more actively managed with annual turnover of: 71.00 vs. VSCIX (17.00). FJACX has a lower initial minimum investment than VSCIX: FJACX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. FJACX (16.04). VSCIX return over 5 years is better than : 35.13 vs. FJACX (-5.54).
FJACXVSCIXFJACX / VSCIX
Total Expense Ratio0.000.03-
Annual Report Gross Expense Ratio0.000.03-
Fund Existence13 years29 years-
Gain YTD15.85114.591109%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.96B189B1%
Annual Yield % from dividends0.931.2376%
Returns for 1 year16.0422.5871%
Returns for 3 years14.2543.4433%
Returns for 5 years-5.5435.13-16%
Returns for 10 years34.05156.0722%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C